Retrospective Cohort Study
Copyright
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Hepatol. Jun 27, 2021; 13(6): 686-698
Published online Jun 27, 2021. doi: 10.4254/wjh.v13.i6.686
Table 1 Characteristics of patients and hospitals and individual effects on mortality, length of stay and total charges
Study time period 1998-2017 Individual effect (Type III test, P value) Mortality Length of stay Total charges BCS patients' characteristics Age 50.50 (0.19) < 0.001 0.052 < 0.001 Female 55.19 (0.54) 0.003 0.001 < 0.001 Race 0.138 0.013 < 0.001 1: White 56.03 (0.54) 2: Black 13.26 (0.37) 3: Hispanic 9.56 (0.32) 4: Asian/Pacific Islander 2.56 (0.17) 6: Other 3.65 (0.2) 9: Unknown 14.93 (0.39) Primary payer < 0.001 0.002 < 0.001 1: Medicare 33.17 (0.52) 2: Medicaid 18.42 (0.42) 3: Private insurance 40.20 (0.54) 6: Other 8.21 (0.3) Hospital characteristics Hospital size 0.014 < 0.001 < 0.001 1: Small 9.81 (0.32) 2: Medium 18.92 (0.43) 3: Large 71.27 (0.49) Hospital location and teaching status 0.195 < 0.001 < 0.001 1: Rural 6.89 (0.28) 2: Urban nonteaching 24.24 (0.47) 3: Urban teaching 68.87 (0.51) Hospital region 0.533 0.010 < 0.001 1: Northeast 21.84 (0.45) 2: Midwest 22.15 (0.46) 3: South 33.45 (0.52) 4: West 22.57 (0.46) Clinical characteristics Ascites 29.93 (0.5) < 0.001 < 0.001 < 0.001 Acute kidney injury 18.84 (0.43) < 0.001 < 0.001 < 0.001 Hepatic cirrhosis with no mention of alcohol 18.65 (0.43) 0.901 0.031 0.838 Cancer 17.26 (0.41) < 0.001 0.002 0.010 Portal hypertension 16.57 (0.41) 0.029 0.898 0.000 Hepatic encephalopathy 9.59 (0.32) < 0.001 < 0.001 < 0.001 Portal vein thrombosis 7.92 (0.3) 0.006 0.372 0.073 Esophageal varices without bleeding 7.44 (0.29) 0.002 0.324 0.091 Acute respiratory Failure 7.03 (0.28) < 0.001 < 0.001 < 0.001 HCC 6.93 (0.28) < 0.001 < 0.001 0.543 Acute blood loss anemia/hemorrhagic 6.62 (0.27) 0.008 < 0.001 < 0.001 IVC thrombosis 6.39 (0.27) < 0.001 < 0.001 < 0.001 Sepsis 6.10 (0.26) < 0.001 < 0.001 < 0.001 Alcoholic cirrhosis 5.73 (0.25) 0.113 0.731 0.140 Acute liver failure 5.60 (0.25) < 0.001 < 0.001 < 0.001 Hepatorenal syndrome 3.29 (0.2) < 0.001 < 0.001 < 0.001 Variceal bleeding 3.20 (0.19) 0.107 0.160 0.001 Spontaneous bacterial peritonitis 2.83 (0.18) < 0.001 < 0.001 < 0.001 Intestinal infarct/acute vascular insufficiency 2.11 (0.16) < 0.001 < 0.001 < 0.001 Elixhauser Comoridity Score excluding liver disease 9.38 (0.12) < 0.001 < 0.001 < 0.001
Table 2 Trends in outcomes of interest
1998-2017 (unweighted: 8435, weighted: 41119) 1998 (unweighted: 262, weighted: 1367) 2017 (unweighted: 680, weighted: 3400) APC (95%CI) P value for APC Procedures Number of procedures 2.64 (0.03) 3.09 (0.20) 2.42 (0.13) -0.51% (-1.09%, 0.06%) 0.082 Paracentesis 18.41 (0.42) 28.56 (2.82) 16.47 (1.42) -1.67% (-2.53%, -0.81%) 0.000 Upper endoscopy 10.94 (0.34) 13.08 (2.06) 11.91 (1.24) -0.17% (-1.31%, 0.97%) 0.766 Liver biopsy 6.24 (0.26) 10.35 (1.9) 5.15 (0.85) -4.01% (-5.42%, -2.58%) < 0.0001 Portosystemic shunt/TIPS 3.63 (0.2) 6.12 (1.54) 2.94 (0.65) -4.95% (-6.78%, -3.09%) < 0.0001 Liver transplantation 1.9 (0.15) 1.29 (0.75) 2.06 (0.54) -2.68% (-5.26%, -0.02%) 0.048 Disposition of patient 1: Discharged to home or selfcare 58.8(0.54) 50.71 (3.12) 55.96 (1.91) -0.28% (-0.77%, 0.21%) 0.262 6: Home health care 13.49 (0.37) 12.04 (2.04) 17.23 (1.45) 3.31% (2.20%, 4.43%) < 0.0001 5: Transfer: other type of facility 11.12 (0.34) 10.21 (1.89) 12.08 (1.25) 1.87% (0.70%, 3.06%) 0.002 20: Died in hospital 8.74 (0.31) 18.17 (2.44) 7.66 (1.02) -4.31% (-5.50%, -3.10%) < 0.0001 2: Transfer: short-term hospital 6.8 (0.28) 8.25 (1.71) 5.6 (0.88) -1.26% (-2.66%, 0.17%) 0.084 7: Against medical advice 1 (0.11) 0.61 (0.43) 1.47 (0.46) 2.94% (-1.02%, 7.07%) 0.148 Outcomes Number of deaths 737 (Unweighted); 3591 (Weighted) 46 (Unweighted); 249 (Weighted) 52 (Unweighted); 260 (Weighted) Mortality rate per 1000000 United States populations 0.9 0.8 -0.29% (-0.86%, 0.27%) 0.309 Mortality rate per 1000000 inpatients 8.87 8.55 0.34% (-0.23%, 0.92%) 0.243 Mortality rate among BCS inpatients 0.09 0.18 0.08 -4.41% (-4.95%, -3.88%) < 0.0001 Length of stay (d) 8.84 (0.13) 12.73 (1.01) 7.64 (0.36) -2.04% (-2.67%, -1.41%) < 0.0001 Average total charges in 2017 dollars 94440.04 (1996.06) 95515.01 (9483.24) 103850.98 (8183.79) 1.15% (0.35%, 1.96%) 0.005
Table 3 Multivariate model on mortality
Response Beta estimate Standard error P value for beta Odds ratio (95%CI) Age 0.024 0.003 < 0.0001 1.024 (1.019, 1.029) Acute respiratory Failure Yes (reference = No) 1.652 0.109 < 0.0001 5.219 (4.211, 6.468) Intestinal infarct/acute vascular insufficiency Yes (reference = No) 1.422 0.201 < 0.0001 4.143 (2.795, 6.142) Acute liver failure Yes (reference = No) 1.286 0.119 < 0.0001 3.617 (2.864, 4.567) Hepatorenal syndrome Yes (reference = No) 1.123 0.147 < 0.0001 3.072 (2.302, 4.101) Cancer Yes (reference = No) 0.882 0.098 < 0.0001 2.415 (1.993, 2.927) Acute kidney injury Yes (reference = No) 0.803 0.092 < 0.0001 2.232 (1.862, 2.675) Sepsis/severe sepsis/septic shock Yes (reference = No) 0.635 0.122 < 0.0001 1.886 (1.484, 2.398) Hepatic encephalopathy Yes (reference = No) 0.280 0.117 0.020 1.323 (1.052, 1.662) Elixhauser Comorbidity Score excluding liver disease 0.026 0.004 < 0.0001 1.027 (1.019, 1.034)
Table 4 Multivariate model on length of stay
Response Beta estimate Standard error P value for Beta P value for type 3 test Primary payer 1: Medicare (reference) 0.000 - - 0.022 2: Medicaid 0.053 0.037 0.144 3: Private insurance 0.084 0.030 0.005 Hospital bed size 1: Small (reference) 0.000 - - < 0.0001 2: Medium 0.113 0.049 0.021 3: Large 0.293 0.042 <.0001 Hospital location and teaching status 1: Rural (reference) 0.000 - - < 0.0001 2: Urban nonteaching 0.206 0.054 <.0001 3: Urban teaching 0.433 0.050 <.0001 Hospital region 1: Northeast 0.171 0.038 <.0001 < 0.0001 2: Midwest 0.017 0.038 <.0001 3: South 0.055 0.034 <.0001 4: West (reference) 0.000 Complications Acute liver failure Yes (reference = No) 0.223 0.057 < 0.0001 < 0.0001 Acute respiratory Failure Yes (reference = No) 0.380 0.052 < 0.0001 < 0.0001 Acute kidney injury Yes (reference = No) 0.255 0.035 < 0.0001 < 0.0001 Ascites Yes (reference = No) 0.118 0.028 < 0.0001 < 0.0001 Spontaneous bacterial peritonitis Yes (reference = No) 0.480 0.076 < 0.0001 < 0.0001 IVC thrombosis Yes (reference = No) 0.138 0.052 0.008 0.008 Intestinal infarct/acute vascular insufficiency Yes (reference = No) 0.383 0.088 < 0.0001 < 0.0001 cancer Yes (reference = No) -0.278 0.036 < 0.0001 < 0.0001 Elixhauser Comorbidity Score excluding liver disease 0.019 0.001 < 0.0001 < 0.0001
Table 5 Multivariate model on total charges
Response Estimate Standard error P value for beta P value for type 3 test Race 1: White (reference) 0.000 - - < 0.0001 2: Black -0.037 0.026 0.162 3: Hispanic 0.015 0.031 0.613 4: Asian/Pacific Islander 0.136 0.058 0.019 6: Other 0.082 0.046 0.077 9: Unknown -0.185 0.025 < 0.0001 Hospital bed size 1: Small (reference) 0.000 - - < 0.0001 2: Medium 0.080 0.034 0.018 3: Large 0.169 0.029 < 0.0001 Hospital location and teaching status 1: Rural (reference) 0.000 - - < 0.0001 2: Urban nonteaching 0.428 0.037 < 0.0001 3: Urban teaching 0.552 0.034 < 0.0001 Hospital region 1: Northeast -0.195 0.027 < 0.0001 < 0.0001 2: Midwest -0.333 0.027 < 0.0001 3: South -0.330 0.024 < 0.0001 4: West (reference) 0.000 - - Complications Acute liver failure Yes (reference = No) 0.078 0.039 0.044 0.044 Acute respiratory Failure Yes (reference = No) 0.204 0.036 < 0.0001 < 0.0001 Acute kidney injury Yes (reference = No) 0.146 0.025 < 0.0001 < 0.0001 Hepatorenal syndrome Yes (reference = No) -0.132 0.050 0.008 0.009 IVC thrombosis Yes (reference = No) 0.075 0.035 0.035 0.035 Acute blood loss anemia/ hemorrhagic Yes (reference = No) 0.155 0.035 < 0.0001 < 0.0001 Cancer Yes (reference = No) -0.052 0.025 0.037 0.037 Elixhauser Comoridity Score excluding liver disease 0.005 0.001 < 0.0001 < 0.0001 Other variables Number of procedures 0.118 0.004 < 0.0001 < 0.0001 Length of stay 0.054 0.001 < 0.0001 < 0.0001